Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Collaborative Home Visits to Reduce Hospital Readmissions and Improve Medication Use During Transitions of Care

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02087072
Recruitment Status : Unknown
Verified October 2014 by Stuart Beatty, Ohio State University.
Recruitment status was:  Active, not recruiting
First Posted : March 14, 2014
Last Update Posted : October 22, 2014
Sponsor:
Collaborator:
American Society of Health-System Pharmacy Foundation
Information provided by (Responsible Party):
Stuart Beatty, Ohio State University

Brief Summary:

The primary objective is to develop a sustainable practice model emphasizing home visits by a collaborative physician and pharmacist team to decrease unplanned emergency department visits and hospital readmissions at 30 and 90 days for high-risk home bound patients. Secondary objectives include (1) tracking the number, type, and severity of adverse drug events (ADE) and potential adverse drug events (pADE) that occur following hospital discharge and (2) resolving any identified ADE and pADE within 7 days of hospital discharge.

Adult patients will be scheduled for a home visit by the Healthy at Home Columbus program at the time of hospital discharge. The home visit will occur within 7 days of hospital discharge and will consist of a complete hospital and medication review by a physician or nurse practitioner and a pharmacist (including all lab tests, imaging studies, medication changes, and proposed plan of care at the time of discharge). The investigators hypothesize these home visits will reduce 30 and 90 days hospital readmission rates and ED visits.

The number of emergency department visits and unplanned hospital readmissions will be tracked at 30 and 90 days following discharge from the hospitalization that led to study enrollment. A comparison cohort of patients discharged in the 12 months prior to study initiation will be used to compare the effectiveness of the home visit program. The number and type of adverse drug events (ADE) and potential adverse drug events (pADE) that occur during transitions of care will also be characterized. All ADE and pADE will be resolved during the initial home visit and will be classified based on severity. All ADE and pADE will be evaluated independently by two pharmacist reviewers; each reviewer will independently assign a severity rating to each ADE and pADE.


Condition or disease Intervention/treatment
Transitional Care Coordination Home Visits Other: Collaborative visit with provider and pharmacist

Layout table for study information
Study Type : Observational
Estimated Enrollment : 150 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: COLLABORATIVE HOME VISITS TO REDUCE HOSPITAL READMISSIONS AND IMPROVE MEDICATION USE DURING TRANSITIONS OF CARE
Study Start Date : October 2013
Estimated Primary Completion Date : December 2014
Estimated Study Completion Date : December 2014

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Recently discharged homebound patients Other: Collaborative visit with provider and pharmacist



Primary Outcome Measures :
  1. Hospital Readmission [ Time Frame: 30 days ]

Secondary Outcome Measures :
  1. Emergency Department Visit [ Time Frame: 30 days ]

Other Outcome Measures:
  1. Number of drug related problems identified [ Time Frame: 30 days ]
  2. Type of drug related problems identified [ Time Frame: 30 days ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients will be selected from the OSU Healthy at Home program that have been recently discharged from the hospital.
Criteria

Inclusion Criteria:

  • Adult patients discharged from the hospital in the last 7 days and with more than two chronic conditions and significant obstacles to accessing care in an office setting are eligible for study participation

Exclusion Criteria:

  • Adult patients able to access care in an office setting.
  • Adult patients discharged from the hospital greater than 7 days prior to the office visit.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02087072


Locations
Layout table for location information
United States, Ohio
The Ohio State University Division of General Internal Medicine Martha Morehouse
Columbus, Ohio, United States, 43221
Sponsors and Collaborators
Ohio State University
American Society of Health-System Pharmacy Foundation
Layout table for additonal information
Responsible Party: Stuart Beatty, Assistant Professor of Clinical Pharmacy, Ohio State University
ClinicalTrials.gov Identifier: NCT02087072    
Other Study ID Numbers: 2013H0185
First Posted: March 14, 2014    Key Record Dates
Last Update Posted: October 22, 2014
Last Verified: October 2014
Keywords provided by Stuart Beatty, Ohio State University:
home visits
transitions of care
pharmacist